A: Our liposomes are very small, typically between 50 - 200 nm
For patients with coexisting type 2 diabetes or obesity, coordinate care between your endocrinologist and gastroenterologist to ensure treatment decisions consider both conditions
Retatrutide is currently undergoing large-scale Phase 3 trials (the TRIUMPH program)
Are there alternatives to GLP-1 Based Therapies
It supports strength, mobility, insulin sensitivity, posture, balance, healthy aging, and long-term weight maintenance
Alcune metanalisi segnalano un possibile aumento del rischio di calcoli alla colecisti e un moderato incremento degli enzimi pancreatici, anche se il rischio di pancreatite non sembra significativamente superiore al placebo